1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. XENCOR INC
Xencor Inc XNAS: XNCR

Xencor Inc Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody pr...

Read More
11.87 0.55 (4.86%)
36.49% Fall from 52W High
835.9K
XNAS Volume

XNAS 09 Mar, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Xencor Inc is on 11 Mar 2026 for the purpose of Barclays 28th Annual Global Healthcare Conference See details
Durability score
Low Financial Strength
16.7 / 100
Valuation Score
Expensive Valuation
21.2 / 100
Momentum Score
Technically Neutral
55.0 / 100
Momentum Trap These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution View Similar Embed DVM
Analyst Price Target
29
1Yr Price target upside is 143%
12 analysts

11

S

9

W

1

O

2

T

SWOT Analysis

Xencor Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..